Fariba
Fariba Ariaei, Middletown, PA US
Patent application number | Description | Published |
---|---|---|
20090326401 | Method and System for Dynamical Systems Modeling of Electrocardiogram Data - Electrocardiogram data is received in association with a subject, the electrocardiogram data comprising a series of RR intervals and a series of QT intervals. A first value which indicates an amount by which uncertainty associated with the QT intervals is reduced given the RR intervals is generated. A second value which indicates an amount by which uncertainty associated with the RR intervals is reduced given the QT intervals is generated. The subject is determined to be associated with a low risk of cardiac dysfunction responsive to the first value exceeding the second value and a result of the determination is provided. | 12-31-2009 |
Fariba Ghiasi, Frankfurt DE
Patent application number | Description | Published |
---|---|---|
20100293724 | USE PF ALKANOLAMINES FOR THICKENING OXIDATIVE COLOURING EMULSION - The present invention relates to the use of alkanolamines for thickening oxidative coloring compositions. More particularly, the present invention relates to the use of alkanolamines for thickening ready to use oxidative coloring composition based on mixing two compositions wherein one comprises at least one oxidative dyeing precursor and the other comprises as least one oxidizing agent. | 11-25-2010 |
20120030883 | USE OF ALKANOLAMINES FOR THICKENING OXIDATIVE COLOURING EMULSION - The present invention relates to the use of alkanolamines for thickening oxidative coloring compositions. More particularly, the present invention relates to the use of alkanolamines for thickening ready to use oxidative coloring composition based on mixing two compositions wherein one comprises at least one oxidative dyeing precursor and the other comprises as least one oxidizing agent. | 02-09-2012 |
20120192889 | COMPOSITION AND METHOD FOR COLOURING HAIR - A composition and method oxidative colours hair based on at least one oxidative dye precursor and comprises at least one fatty acid soap, preferably selected from sodium, potassium soaps and their mixtures. The composition is preferably applied onto hair as foam from a non-aerosol foamer vessel after mixing with a composition comprising at least one oxidizing agent | 08-02-2012 |
Fariba Jousheghany, Little Rock, AR US
Patent application number | Description | Published |
---|---|---|
20130095480 | Chondroitin Sulfate Sulfotransferases and Proteoglycans as Cancer Biomarkers: Use of Expression and Methalytion Status - A method of determining a prognosis of a cancer in a human comprising: determining expression level of CHST11 in a cancer tissue sample or determining methylation status of CHST11 gene in a cancer tissue sample. CHST11 is Carbohydrate (Chondroitin 4) Sulfotransferase 11. | 04-18-2013 |
20150315654 | Chondroitin Sulfate Sulfotransferases and Proteoglycans as Cancer Biomarkers: Use of Expression and Methalytion Status - A method of determining a prognosis of a cancer in a human comprising: determining expression level of CHST11 in a cancer tissue sample or determining methylation status of CHST11 gene in a cancer tissue sample. CHST11 is Carbohydrate (Chondroitin 4) Sulfotransferase 11. | 11-05-2015 |
Fariba Khandanian, Bispingen DE
Patent application number | Description | Published |
---|---|---|
20140311888 | PROCESS FOR THE PREPARATION OF AQUEOUS SOLUTIONS - The invention relates to a vapor-compression method. The aim of the invention is to provide such a method respectively a system with which a distillation with a further reduced energy requirement is possible, which simultaneously operates reliably, with little maintenance, and with only little available power, in particular when starting, and which is able to handle fluctuations in the available power. This is achieved in that an aqueous solution is preheated and fed to an evaporator at a lower end in order to generate vapor. The vapor is conducted from an upper end of the evaporator to a compressor (V) in order to be compressed. The vapor that is compressed in the compressor (V) is used to supply energy to the evaporator. The vapor that is thus cooled or optionally at least partly condensed is used to preheat the aqueous solution. Furthermore, the method according to the invention is characterized in that the preheated aqueous solution in the evaporator is heated in evaporator tubes around which the compressed vapor is flushed, and at least one heater that is arranged diagonally in particular is provided in or upstream of the evaporator. | 10-23-2014 |
Fariba Nayeri, Linkoping SE
Patent application number | Description | Published |
---|---|---|
20080261233 | Assessment of Biological Activity of Hepatocyte Growth Factor (Hgf) - In the present invention the methods for recognition of biologically active hepatocyte growth factor efficient for using in therapeutic components are presented. The biological activity can be determined using: i) an in vitro model of restitution of damaged cells, and/or ii) affinity measurements or epitope mapping using SPR, with the C-met receptor, anti-HGF antibodies or polysaccharides such as dextran, and/or iii) an animal model of hair growth rates. By these methods the activity of HGF in body secretions can be evaluated as well. | 10-23-2008 |
20090068179 | Methods for Inhibiting Carcinogenesis and/or Metastasis in an Individual with Endogenous C-Met Ligands and Inhibitors - Methods for inhibiting carcinogenesis and/or metastasis in an individual comprise administering to the individual an effective amount of endogenous c-met ligand or fragment thereof such as endogenous anti c-met immunoglobulin, native and/or recombinant; endogenous biological active Hepatocyte Growth Factor (HGF), native and/or recombinant, and/or a combination thereof. | 03-12-2009 |
20100160223 | Synergetic Effects of HGF and Antibacterial Treatment - A method of treating an infection and/or an injury caused or complicated by an infection in a mammal, comprising providing an antibiotic or fungicide and either HGF or a polypeptide exhibiting HGF activity to said mammal. In one embodiment, the injury is not a chronic skin ulcer. | 06-24-2010 |
20120094310 | METHOD FOR DETERMINING BIOLOGICALLY ACTIVE HGF - The present invention relates to a for determining the presence, absence or amount of biologically active or inactive HGF in a sample, comprising the steps: bringing the sample in contact with a gel comprising a HGF binding component of the extracellular matrix or cell membrane, adding toluidine blue to the gel, correlating the colour of the gel and/or a liquid in contact with the gel with the presence, absence or amount of biologically active HGF in the sample. It also relates to a kit of parts comprising toluidine blue and a gel comprising at least one HGF-binding component of the extracellular matrix or cell membrane, such as a proteoaminoglycan or a glucosaminoglycan, and optionally buffers, vials and sampling instruments and to a gel comprising at least one HGF-binding component of the extracellular matrix or cell membrane, such as a proteoaminoglycan or a glucosaminoglycan, toluidine blue and HGF. | 04-19-2012 |
20150037908 | NEW METHOD FOR RAPID DETECTION OF HEPATOCYTE GROWTH FACTOR IN BIOLOGICAL FLUIDS - The present invention relates to a method for determining the presence, absence or amount of biologically active HGF in a sample, comprising the steps (i) bringing the sample in contact with a first porous solid phase comprising a HGF binding component of the extracellular matrix or cell membrane, and an indicator composition comprising bromothymol blue and a quaternary ammonium compound; and (ii) correlating the colour of the porous solid phase with the presence, absence or amount of biologically active HGF in the sample. It further relates to a device comprising a first porous solid phase comprising at least one HGF-binding component of the extracellular matrix or cell membrane, and an indicator composition comprising bromothymol blue and a quaternary ammonium compound. | 02-05-2015 |
Fariba Nemati, Paris FR
Patent application number | Description | Published |
---|---|---|
20130303439 | CHIMERIC PEPTIDES INCLUDING A PENETRATING PEPTIDE AND A BINDING DOMAIN OF PP2A CATALYTIC SUBUNIT TO CASPASE-9 - The invention related to chimeric peptides including a penetrating peptide and a binding domain of PP2A catalytic subunit to caspase-9 which have pro-apoptotic activity. These chimeric peptides may be used for the treatment of hyperproliferative disorders. | 11-14-2013 |
20140364376 | CELL-PENETRATING PEPTIDES - The invention relates to a cell-penetrating peptide, optionally linked to a pro-apoptotic peptide, useful as pro-apoptotic agents, for inhibition of in vitro cell proliferation and for treatment of tumors. | 12-11-2014 |
20150030699 | ANTI-TUMOR ADJUVANT THERAPY - The invention relates to a chimeric peptide construct comprising a cell penetrating peptide linked to a pro-apoptotic peptide, for use in treating a tumor in combination with an anti-tumor agent, preferably a chemotherapeutic agent. | 01-29-2015 |
Fariba Sepahvand, Khoramabad IR
Patent application number | Description | Published |
---|---|---|
20140094421 | HERBAL MEDICINAL COMPOSITION FOR TREATMENT OF WOMEN INFERTILITY AND A METHOD OF PREPARING THE SAME - The embodiments herein provide a herbal medicinal composition for effectively treating a women infertility and a method for preparing the same. The composition comprises elm tree wood, a camel fat and water. The composition is prepared by taking several pieces of elm tree wood in a container and adding camel fat and water to the container. The container is heated for 120 minutes. The color of the contents of the container changes to bright red upon boiling. The mixture is filtered and cooled down at room temperature. The composition is taken by a patient in the morning for at least first seven days of the menstrual cycle. | 04-03-2014 |
Fariba Sepahvand, Khoram Abad IR
Patent application number | Description | Published |
---|---|---|
20160022755 | HERBAL GEL FROM CHESTNUT SEED COAT FOR PELVIC FLOOR MUSCLE RELAXATION IN WOMEN AND A METHOD OF SYNTHESIZING THE SAME - The embodiments herein disclose a method for extracting the herbal extract from acorn or oak nut of | 01-28-2016 |
Fariba Soleymanzadeh, Danbury, CT US
Patent application number | Description | Published |
---|---|---|
20080280904 | N-Substituted Pyridinone or Pyrimidinone Compounds Useful as Soluble Epoxide Hydrolase Inhibitors - Disclosed are compounds active against soluble epoxide hydrolase (sEH), compositions thereof and methods of using and making same. | 11-13-2008 |
20090099184 | Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors - Disclosed are compounds active against soluble epoxide hydrolase (sEH), compositions thereof and methods of using and making same. | 04-16-2009 |
20090111791 | Soluble Epoxide Hydrolase Inhibitors and Methods of Using Same - Disclosed are compounds active against soluble epoxide hydrolase (sEH), compositions thereof and methods of using and making same. | 04-30-2009 |
20100121051 | UROTENSIN II RECEPTOR ANTAGONISTS - Compounds of the formula (I) | 05-13-2010 |
20110118262 | Pyrrolidinyl and Piperidinyl Compounds Useful as NHE-1 Inhibitiors - Disclosed are compounds of formula (I) and compositions of the present invention which are inhibitors of the sodium proton exchanger isoform-1 (NHE-I). Also disclosed are methods of using and making the same. | 05-19-2011 |
20120165322 | RHO KINASE INHIBITORS - The present invention relates to compounds of formula (I): | 06-28-2012 |
20120270868 | RHO KINASE INHIBITORS - The present invention relates to compounds of formula (I): | 10-25-2012 |
20130109679 | HETEROCYCLIC COMPOUNDS CONTAINING AN INDOLE CORE | 05-02-2013 |
20130203729 | SOLUBLE GUANYLATE CYCLASE ACTIVATORS - The present invention relates to compounds of formula (I): | 08-08-2013 |
20140045813 | HETEROAROMATIC COMPOUNDS AS BTK INHIBITORS - The present invention encompasses compounds of the formula (I) | 02-13-2014 |
Fariba Tajabadi, Kerman IR
Patent application number | Description | Published |
---|---|---|
20110220192 | SINGLE-SIDED DYE-SENSITIZED SOLAR CELLS HAVING A VERTICAL PATTERNED STRUCTURE - A single-sided dye-sensitized solar cell having a vertical patterned structure is disclosed. A patterned nonconductive insulating layer is formed directly over first portions of a conductive substrate. An electrocatalyst material layer is formed directly over second portions of the conductive substrate, where the second portions of the conductive substrate do not overlap with the first portions of the conductive substrate. A second conductive layer is formed directly over the patterned nonconductive insulating layer and a porous layer is formed directly over the second conductive layer. An electrolyte is formed over the porous layer and the electrocatalyst material layer and a transparent sheet is formed over the electrolyte. | 09-15-2011 |